Invesco Ltd. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 67 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,153
-7.2%
23,818
-25.6%
0.00%
Q2 2023$29,273
-79.3%
31,992
-87.0%
0.00%
Q4 2022$141,658
+79.3%
245,507
-2.0%
0.00%
Q3 2022$79,000
-15.1%
250,524
-5.3%
0.00%
Q2 2022$93,000
-53.7%
264,550
-5.5%
0.00%
Q1 2022$201,000
-53.4%
279,958
+47.1%
0.00%
Q4 2021$431,000
-26.1%
190,364
-5.9%
0.00%
Q3 2021$583,000
-17.9%
202,385
+8.1%
0.00%
Q2 2021$710,000
+30.0%
187,222
+16.2%
0.00%
Q1 2021$546,000
+557.8%
161,111
+442.5%
0.00%
Q4 2020$83,000
-94.5%
29,697
-95.1%
0.00%
-100.0%
Q3 2020$1,522,000
-89.7%
606,346
-44.5%
0.00%
-80.0%
Q2 2020$14,835,000
+72.4%
1,092,440
-3.8%
0.01%
+25.0%
Q1 2020$8,605,000
-7.9%
1,135,256
-0.5%
0.00%
+33.3%
Q1 2019$9,347,000
+2954.6%
1,141,290
+3449.7%
0.00%
Q1 2018$306,000
-89.6%
32,152
-83.7%
0.00%
-100.0%
Q4 2017$2,932,000
-74.6%
197,173
-66.5%
0.00%
-75.0%
Q3 2017$11,565,000
+567.0%
587,932
+387.6%
0.00%
+300.0%
Q2 2017$1,734,000
+180.6%
120,578
+75.7%
0.00%
Q1 2016$618,000
+10200.0%
68,611
+11958.2%
0.00%
Q2 2015$6,0005690.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders